Literature DB >> 6163466

Thymidine catabolism and the reutilization of its degradative products in Tetrahymena pyriformis. Metabolism of [2,6-14C2]thymidine and [2-14C]methylmalonic acid.

M A Niemann, J Berech.   

Abstract

The operation of reductive pyrimidine catabolic and reutilization pathway in Tetrahymena pyriformis was investigated. Consistent with the proposed catabolic interconversions, radioactivity from [2,6-14C2]thymidine was recovered in respired CO2 30 min after its addition to the culture, whereas, consistent with the proposed anabolic interconversions, over 50% of the incorporated label was recovered in cellular macromolecules other than DNA 12 h after its addition. The chromatographic recovery of 14C radioactivity in monosaccharides from [2,6-14C2]thymidine as well as from [2-14C]methylmalonic acid, a key reutilization intermediate in this proposed pathway, further substantiated the operation of the required anabolic interconversions in this organism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163466     DOI: 10.1016/0005-2787(81)90124-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.

Authors:  E M Cretton; Z Zhou; L B Kidd; H M McClure; S Kaul; M J Hitchcock; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

2.  Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.

Authors:  S Kaul; K A Dandekar
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.